Cardiovascular Disease (CVD)
18
3
4
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Towards Personalized Nutrition With SCAPIS2-HOME
Study of the Progression of Chronic Cardiovascular Conditions
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
Veteran Peer Coaches Optimizing and Advancing Cardiac Health
A Genomic Approach for Clopidogrel in Caribbean Hispanics
Beating the Blues for Your Heart
Women's Advanced Risk-assessment in Manitoba
Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled With Primary Prevention
Carolina Heart Alliance Networking for Greater Equity
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
West Philadelphia Consortium Randomized Control Trial
The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session
Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
A Randomized Trial of Patient Financial Incentives to Reduce CVD Risk
The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study